公开(公告)号：US08538868B2

公开(公告)日：2013-09-17

申请号：US13295747

申请日：2011-11-14

Applicant: Serge Rivest ,  Michael King ,  Richard Clark

Inventor： Serge Rivest ,  Michael King ,  Richard Clark

IPC: G06Q40/00

CPC classification number: G06Q40/06 ,  G06Q20/10 ,  G06Q20/102 ,  G06Q30/08 ,  G06Q40/00 ,  G06Q40/02 ,  G06Q40/025

Abstract: A system and method of preparing a transfer document for a client to transfer services provided by counterparties that require recurring transactions using a first account to use a second account is provided. A cashflow analysis for the first account and a cashflow analysis for the second account are performed to determine for each counterparty and each service the desired date to effect the transfer to avoid undesirable cashflow spikes or interruptions in both accounts. A transfer document for transferring services requiring recurring transactions for each counterparty is electronically generated via at least one computer. Each transfer document identifies at least the service to be transferred, the client, the second account, the desired date for the transfer and proof of authorization from the client. A replica of an account document selected according to the service being transferred and the second account is included on the transfer document.

Abstract translation: 提供了一种用于为客户端传送转让文件的系统和方法，用于传送由交易对手方提供的服务，该交易对手方需要使用第一个帐户使用第二个帐户的定期交易。 执行第一个帐户的现金流量分析和第二个账户的现金流量分析，以确定每个交易对手和每个服务是实现转账的期望日期，以避免两个帐户中不必要的现金流尖峰或中断。 通过至少一台计算机电子地生成用于转移需要每个交易对手的经常性交易的服务的转让文件。 每个转让文件至少识别要传输的服务，客户端，第二个帐户，转移的期望日期和客户端的授权证明。 根据正在转让的服务选择的帐户文件的副本和第二个帐户被包括在转让文件中。

公开(公告)号：US08163769B2

公开(公告)日：2012-04-24

申请号：US10387318

申请日：2003-03-12

Applicant: David Anderson ,  Bruce Beutel ,  Todd D. Bosse ,  Richard Clark ,  Curt Cooper ,  Peter Dandliker ,  Caroline David ,  Yu-Gui Gu ,  Todd Matthew Hansen ,  Mira Hinman ,  Douglas Kalvin ,  Daniel P. Larson ,  Linda Lynch ,  Zhenkun Ma ,  Christopher Motter ,  Fabio Palazzo ,  Teresa Rosenberg ,  Tamara Rehm ,  William Sanders ,  Michael Tufano ,  Rolf Wagner ,  Moshe Weitzberg ,  Hong Yong ,  Tianyuan Zhang

Inventor： David Anderson ,  Bruce Beutel ,  Todd D. Bosse ,  Richard Clark ,  Curt Cooper ,  Peter Dandliker ,  Caroline David ,  Yu-Gui Gu ,  Todd Matthew Hansen ,  Mira Hinman ,  Douglas Kalvin ,  Daniel P. Larson ,  Linda Lynch ,  Zhenkun Ma ,  Christopher Motter ,  Fabio Palazzo ,  Teresa Rosenberg ,  Tamara Rehm ,  William Sanders ,  Michael Tufano ,  Rolf Wagner ,  Moshe Weitzberg ,  Hong Yong ,  Tianyuan Zhang

IPC: A61K31/04 ,  C07D215/38

CPC classification number: C07D471/04

Abstract: Antibacterials having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods of prophylaxis and treatment of bacterial infections using the compounds are disclosed.

Abstract translation: 公开了具有式（I）的抗菌剂及其前体药物的盐，前药和盐，用于制备本方法中使用的化合物和中间体的方法，含该化合物的组合物，以及使用该化合物预防和治疗细菌感染的方法。

公开(公告)号：US07511475B2

公开(公告)日：2009-03-31

申请号：US10537267

申请日：2003-12-01

Applicant: Christophe Maerky ,  Geraint Jewell ,  Richard Clark ,  Paul Stewart

Inventor： Christophe Maerky ,  Geraint Jewell ,  Richard Clark ,  Paul Stewart

IPC: G01B7/14

CPC classification number: F16K31/0679 ,  F01L9/04 ,  F01L2009/0436 ,  F01L2009/0448 ,  F01L2009/0469 ,  F16K37/0033 ,  F16K37/0041 ,  G01P3/52 ,  H01F7/122 ,  H01F7/1615 ,  H01F21/06

Abstract: A speed sensor for a moving member (8) comprises means (27; 34) for constituting a magnetic singularity on a portion of the moving member, and a sleeve slidably receiving said portion and including at least an annular coil (20, 21) and an annular permanent magnet (22, 23) disposed on a common axis between annular pole pieces (24, 25).

Abstract translation: 用于移动构件（8）的速度传感器包括用于在移动构件的一部分上构成磁性奇点的装置（27; 34）和可滑动地容纳所述部分并且至少包括环形线圈（20,21）的套筒和 设置在环形极片（24,25）之间的公共轴上的环形永磁体（22,23）。

公开(公告)号：US20090018331A1

公开(公告)日：2009-01-15

申请号：US12199982

申请日：2008-08-28

Applicant: Seiji Yoshikawa ,  Eita Emori ,  Fumiyoshi Matsuura ,  Richard Clark ,  Hironori Ikuta ,  Kazunobu Kira ,  Nobuyuki Yasuda ,  Tadashi Nagakura ,  Kazuto Yamazaki

Inventor： Seiji Yoshikawa ,  Eita Emori ,  Fumiyoshi Matsuura ,  Richard Clark ,  Hironori Ikuta ,  Kazunobu Kira ,  Nobuyuki Yasuda ,  Tadashi Nagakura ,  Kazuto Yamazaki

IPC: C07D498/14 ,  C07D473/04 ,  C07D487/04

CPC classification number: C07D473/30 ,  C07D471/04 ,  C07D473/04 ,  C07D473/06 ,  C07D473/18 ,  C07D473/36 ,  C07D473/40 ,  C07D487/04 ,  C07D491/14

Abstract: The present invention is related to compounds represented by the following formula, or salts or hydrates thereof wherein, T1 represents a 4- to 12-membered heterocyclic group containing one or two nitrogen atoms in the ring, which is a monocyclic or bicyclic structure that may have one or more substituents; X represents a C1-6 alkyl group which may have one or more substituents, or such; Z1 and Z2 each independently represent a nitrogen atom or a group represented by the formula —CR2—; R1 and R2 independently represent a hydrogen atom, a C1-6 alkyl group which may have one or more substituents, or a C1-6 alkoxy group which may have one or more substituents, or such. These are novel compounds that exhibit an excellent DPPIV-inhibiting activity.

Abstract translation: 本发明涉及由下式表示的化合物或其盐或水合物，其中，T1表示在环中含有一个或两个氮原子的4至12元杂环基，其为单环或双环结构，其可以是 具有一个或多个取代基; X表示可以具有一个或多个取代基的C 1-6烷基; Z 1和Z 2各自独立地表示氮原子或由式-CR 2表示的基团; R1和R2独立地表示氢原子，可以具有一个或多个取代基的C 1-6烷基或可以具有一个或多个取代基的C 1-6烷氧基等。 这些是表现出优异的DPPIV抑制活性的新型化合物。

公开(公告)号：US20080132507A1

公开(公告)日：2008-06-05

申请号：US11665385

申请日：2005-10-13

Applicant: Richard Clark ,  Shinsuke Hirota ,  Hiroshi Azuma ,  Kazunobu Kira ,  Nobuhisa Watanabe ,  Tadashi Nagakura ,  Tatsuo Horizoe

Inventor： Richard Clark ,  Shinsuke Hirota ,  Hiroshi Azuma ,  Kazunobu Kira ,  Nobuhisa Watanabe ,  Tadashi Nagakura ,  Tatsuo Horizoe

IPC: A61K31/5375 ,  C07D213/02 ,  C07D239/24 ,  C07D333/02 ,  C07D307/02 ,  C07D215/00 ,  C07D295/00 ,  C07D249/04 ,  C07D241/10 ,  A61P9/10 ,  A61P11/00 ,  A61K31/4965 ,  A61K31/50 ,  A61K31/4192 ,  C07C63/00 ,  C07C57/00 ,  A61K31/19 ,  A61K31/44 ,  A61K31/505 ,  A61K31/381 ,  A61K31/47

CPC classification number: C07D209/48 ,  C07C257/18 ,  C07C311/49 ,  C07C317/14 ,  C07C317/44 ,  C07C337/06 ,  C07D209/08 ,  C07D213/30 ,  C07D213/54 ,  C07D213/71 ,  C07D213/77 ,  C07D213/80 ,  C07D213/82 ,  C07D213/86 ,  C07D213/87 ,  C07D213/89 ,  C07D215/38 ,  C07D233/90 ,  C07D237/20 ,  C07D239/28 ,  C07D239/42 ,  C07D249/18 ,  C07D257/04 ,  C07D295/32 ,  C07D307/68 ,  C07D333/24 ,  C07D471/04

Abstract: A compound represented by the following general formula (1) or a salt thereof or a hydrate of the foregoing is safe while exhibiting suitable physicochemical stability, and is useful as therapeutic or prophylactic agents for diseases associated with thrombus formation. wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc., R2 represents optionally substituted phenyl, etc., R3 represents optionally substituted C6-10 aryl, etc., Z1, Z2 and Z3 each independently represent hydrogen, etc., Z4 represents hydrogen, etc. and X represents a single bond or —CO—, etc.

Abstract translation: 由下列通式（1）表示的化合物或其盐或其水合物是安全的，同时具有合适的物理化学稳定性，并且可用作与血栓形成相关的疾病的治疗或预防剂。 其中R 1a，R 1b，R 1c和R 1d各自独立地表示氢等， O 2表示任选取代的苯基等，R 3表示任选取代的C 6-10芳基等，Z 1，Z 2， Z 3和Z 3各自独立地表示氢等，Z 4表示氢等，X表示单键或-CO-等。

公开(公告)号：US20070225332A1

公开(公告)日：2007-09-27

申请号：US11675410

申请日：2007-02-15

Applicant: Yu Gui Gu ,  Moshe Weitzberg ,  Xiangdong Xu ,  Richard Clark ,  Tianyuan Zhang ,  Qun Li ,  Todd Hansen ,  Hing Sham ,  Bruce Beutel ,  Heidi Camp ,  Xiaojun Wang

Inventor： Yu Gui Gu ,  Moshe Weitzberg ,  Xiangdong Xu ,  Richard Clark ,  Tianyuan Zhang ,  Qun Li ,  Todd Hansen ,  Hing Sham ,  Bruce Beutel ,  Heidi Camp ,  Xiaojun Wang

IPC: A61K31/444 ,  A61K31/4439 ,  A61K31/433 ,  A61K31/427 ,  A61K31/42 ,  C07D417/14 ,  C07D413/02

CPC classification number: C07D277/34 ,  C07D261/08 ,  C07D277/56 ,  C07D413/04 ,  C07D413/12 ,  C07D413/14 ,  C07D417/04 ,  C07D417/14

Abstract: The present invention relates to compounds of formula (I), which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.

Abstract translation: 本发明涉及抑制乙酰辅酶A羧化酶（ACC）并可用于预防或治疗人类代谢综合征，II型糖尿病，肥胖症，动脉粥样硬化和心血管疾病的式（I）化合物。

公开(公告)号：US20070100177A1

公开(公告)日：2007-05-03

申请号：US11506273

申请日：2006-08-11

Applicant: Richard Clark ,  John Davenport ,  Jurgen Louis

Inventor： Richard Clark ,  John Davenport ,  Jurgen Louis

IPC: C10L1/08

CPC classification number: C10L10/02 ,  C10L10/12 ,  Y10S208/95

Abstract: Fuel composition containing a blend of a non-Fischer-Tropsch derived, preferably petroleum derived, diesel base fuel and a Fischer-Tropsch derived kerosene fuel product, optionally together with a Fischer-Tropsch derived gas oil is provided. The Fischer Tropsch derived kerosene fuel product may be included for the purpose of improving the performance of a combustion engine or vehicle which is running or is intended to be run on the fuel composition. It may also be used to reduce vehicle emissions and/or improve the cold flow performance of the composition and/or increase the cetane number of the composition.

Abstract translation: 提供了包含非费 - 托衍生，优选石油衍生的柴油基础燃料和费 - 托衍生的煤油燃料产物的混合物的燃料组合物，任选地与费 - 托衍生的瓦斯油一起。 可以包括费托衍生的煤油燃料产品，目的是改善运行或预期在燃料组合物上运行的内燃机或车辆的性能。 它还可用于减少车​​辆排放和/或改善组合物的冷流性能和/或增加组合物的十六烷值。

公开(公告)号：US20050245592A1

公开(公告)日：2005-11-03

申请号：US11158941

申请日：2005-06-22

Applicant: Shuichi Suzuki ,  Makoto Kotake ,  Mitsuaki Miyamoto ,  Tetsuya Kawahara ,  Akiharu Kajiwara ,  Ieharu Hishinuma ,  Kazuo Okano ,  Syuhei Miyazawa ,  Richard Clark ,  Fumihiro Ozaki ,  Nobuaki Sato ,  Masanobu Shinoda ,  Atsushi Kamada ,  Itaru Tsukada ,  Fumiyoshi Matsuura ,  Yoshimitsu Naoe ,  Taro Terauchi ,  Yoshiaki Oohashi ,  Osamu Ito ,  Hiroshi Tanaka ,  Takashi Musha ,  Motoji Kogushi ,  Tsutomu Kawata ,  Toshiyuki Matsuoka ,  Hiroko Kobayashi ,  Ken-ichi Chiba ,  Akifumi Kimura ,  Naoto Ono

Inventor： Shuichi Suzuki ,  Makoto Kotake ,  Mitsuaki Miyamoto ,  Tetsuya Kawahara ,  Akiharu Kajiwara ,  Ieharu Hishinuma ,  Kazuo Okano ,  Syuhei Miyazawa ,  Richard Clark ,  Fumihiro Ozaki ,  Nobuaki Sato ,  Masanobu Shinoda ,  Atsushi Kamada ,  Itaru Tsukada ,  Fumiyoshi Matsuura ,  Yoshimitsu Naoe ,  Taro Terauchi ,  Yoshiaki Oohashi ,  Osamu Ito ,  Hiroshi Tanaka ,  Takashi Musha ,  Motoji Kogushi ,  Tsutomu Kawata ,  Toshiyuki Matsuoka ,  Hiroko Kobayashi ,  Ken-ichi Chiba ,  Akifumi Kimura ,  Naoto Ono

IPC: A61K20060101 ,  A61K31/403 ,  A61K31/4035 ,  A61K31/4178 ,  A61K31/4184 ,  A61K31/422 ,  A61K31/437 ,  A61K31/454 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/538 ,  A61P20060101 ,  A61P7/02 ,  A61P9/00 ,  A61P9/10 ,  A61P9/12 ,  A61P11/00 ,  A61P11/06 ,  A61P13/12 ,  A61P19/10 ,  A61P25/00 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D20060101 ,  C07D207/22 ,  C07D207/24 ,  C07D207/26 ,  C07D207/263 ,  C07D207/267 ,  C07D207/34 ,  C07D209/44 ,  C07D209/52 ,  C07D209/54 ,  C07D209/62 ,  C07D209/96 ,  C07D213/73 ,  C07D213/74 ,  C07D233/46 ,  C07D233/66 ,  C07D233/88 ,  C07D233/90 ,  C07D235/30 ,  C07D249/14 ,  C07D261/14 ,  C07D401/04 ,  C07D401/06 ,  C07D401/10 ,  C07D401/12 ,  C07D403/04 ,  C07D403/06 ,  C07D403/10 ,  C07D403/12 ,  C07D405/06 ,  C07D409/04 ,  C07D409/06 ,  C07D409/10 ,  C07D413/06 ,  C07D413/10 ,  C07D413/12 ,  C07D413/14 ,  C07D417/06 ,  C07D417/10 ,  C07D471/04 ,  C07D487/04 ,  C07D491/10 ,  C07D498/04 ,  C07D521/00 ,  C07D209/48 ,  C07D471/02

CPC classification number: C07D209/44

Abstract: A 2-iminopyrrolidine derivative represented by the formula: {wherein ring B represents a benzene ring, pyridine ring, etc.; R101-R103 represent hydrogen, halogen, C1-6 alkyl, etc.; R5 represents hydrogen, C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, etc.; R6 represents hydrogen, C1-6 alkyl, C1-6 alkyloxycarbonyl, etc.; Y1 represents a single bond, —CH2—, etc.; Y2 represents a single bond, —CO—, etc.; and Ar represents hydrogen, a group represented by the formula: [wherein R10-R14 represent hydrogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, etc.; and R11 and R12 or R12 and R13 may bond together to form a 5- to 8-membered heterocyclic ring], etc.}, or a salt thereof.

Abstract translation: 由下式表示的2-亚氨基吡咯烷衍生物：其中环B表示苯环，吡啶环等; R 101为-O-，卤素，C 1-6烷基等; R 5表示氢，C 1-6烷基，C 1-6烷氧基-C 1-6烷基 等等 R 6表示氢，C 1-6烷基，C 1-6烷氧基羰基等; Y 1表示单键，-CH 2 - 等; Y 2表示单键，-CO-等; 和Ar表示氢，由下式表示的基团：其中R 10 -R 14表示氢，C 1-6烷基，羟基 C 1-6烷氧基等; 并且R 11和R 12或R 12和R 13可以键合在一起形成5-8个 - 杂环]等，或其盐。

公开(公告)号：US20050014833A1

公开(公告)日：2005-01-20

申请号：US10486396

申请日：2002-08-16

Applicant: Richard Clark ,  Fumiyoshi Matsuura ,  Eita Emori ,  Masanobu Shinoda ,  Shunji Kasai ,  Hideki Yoshitomi ,  Kazuto Yamazaki ,  Takashi Inoue ,  Sadakazu Miyashita ,  Taro Hihara

Inventor： Richard Clark ,  Fumiyoshi Matsuura ,  Eita Emori ,  Masanobu Shinoda ,  Shunji Kasai ,  Hideki Yoshitomi ,  Kazuto Yamazaki ,  Takashi Inoue ,  Sadakazu Miyashita ,  Taro Hihara

IPC: A61P1/00 ,  A61P1/04 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10 ,  A61P9/00 ,  A61P9/10 ,  A61P19/10 ,  A61P29/00 ,  A61P35/00 ,  A61P37/02 ,  C07C233/87 ,  C07C251/60 ,  C07D213/53 ,  C07D263/32 ,  C07D277/56 ,  C07D307/24 ,  C07D307/30 ,  C07D317/32 ,  C07D339/08 ,  C07D405/06 ,  C07D405/12 ,  C07D407/12 ,  C07D413/12 ,  C07D417/12 ,  C07D417/14 ,  C07C229/02 ,  A61K31/195

CPC classification number: C07D213/53 ,  C07C233/87 ,  C07C251/60 ,  C07C2601/02 ,  C07C2601/14 ,  C07D263/32 ,  C07D277/56 ,  C07D307/24 ,  C07D307/30 ,  C07D317/32 ,  C07D339/08 ,  C07D405/06 ,  C07D405/12 ,  C07D407/12 ,  C07D413/12 ,  C07D417/12 ,  C07D417/14

Abstract: The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R1 to R6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A1 and A2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula:  represents a single bond or a double bond; X represents a single bond, an oxygen atom, —NRX1CQ1O—, etc.; Y represents Y1—Y2— (wherein Y1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.

Abstract translation: 本发明提供具有优异的PPAR激动剂作用的新化合物。 更具体地，它提供由下式表示的化合物，其盐，其酯或它们的水合物。 其中a，b和c彼此相同或不同，各自表示0〜4; R 1〜R 6彼此相同或不同，表示氢原子，羟基，氰基，卤素原子等; A 1和A 2彼此相同或不同，各自表示单键，氧原子等; L，M和T各自表示单键，具有1〜6个碳原子的亚烷基等; W表示羧基; 由式表示的部分结构表示单键或双键; X表示单键，氧原子，-NR X 1 C 10 O等; Y表示Y 1 -Y 2 - （其中Y 1表示具有1〜4个取代基的5〜14元芳环等，Y 2表示单键或5〜14个 芳环）; 并且环Z表示具有一至四个选自上述A组的取代基的5至14元芳环，可具有一个或多个杂原子并且可部分饱和。

公开(公告)号：US20050004421A1

公开(公告)日：2005-01-06

申请号：US10892656

申请日：2004-07-16

Applicant: John Pacella ,  Andrew Goldstein ,  Dennis Trumble ,  Richard Clark ,  Fred Moeller ,  George Magovern

Inventor： John Pacella ,  Andrew Goldstein ,  Dennis Trumble ,  Richard Clark ,  Fred Moeller ,  George Magovern

IPC: A61M1/10 ,  A61M1/12 ,  A61N1/362

CPC classification number: A61M1/102 ,  A61M1/1008 ,  A61M1/101 ,  A61M1/1031 ,  A61M1/1086 ,  A61M1/122 ,  A61M2205/3334

Abstract: The present invention pertains to a blood pump device which comprises a blood pump having blood transport ports and cannulae connected to the ports. The blood pump device also comprises a coating material covering the junction between the inner surfaces of the ports and cannulae. This forms a smooth transition so blood can flow unimpeded therefrom and collection cavities for the blood are eliminated. The invention is also related to a method of producing a smooth coating. The present invention is a blood pump device comprising a second portion having a stator mechanism and a rotor mechanism disposed adjacent to and driven by the stator mechanism. The second portion has a journal disposed about the rotor mechanism to provide support therewith. The second portion has an impeller disposed in the chamber and a one-piece seal member for sealing about a shaft of the impeller. The seal member is fixedly attached to the journal so that the seal member is supported by the journal. The present invention is also related to means for providing power to the blood pump so that blood can be pumped through a cannulae. The providing means includes a controller having means for sensing pump failure and an output terminal for actuating a safety occluder in an event of pump failure. Preferably, there is a safety occluder device disposed about the cannulae and in communication with the output terminal. Preferably, the blood pump comprises a motor having stator mechanism and a rotor mechanism driven by the stator mechanism. The sensing means comprises means for determining back electromagnetic force within the stator mechanism. Preferably, the controlling means has means for providing signals indicate of stator current and rotor speed, respectively. The providing means is in communication with the means for determining back electromagnetic force in the stator mechanism.

Abstract translation: 本发明涉及一种血液泵装置，其包括具有血液输送口的血液泵和与端口连接的插管。 血液泵装置还包括覆盖端口的内表面和套管之间的接合处的涂层材料。 这形成平滑的过渡，因此血液可以不受阻碍地流动，消除了血液的收集腔。 本发明还涉及一种制备光滑涂层的方法。 本发明是一种血泵装置，包括具有定子机构的第二部分和与定子机构相邻并由定子机构驱动的转子机构。 第二部分具有围绕转子机构设置的轴颈，以便为其提供支撑。 第二部分具有设置在室中的叶轮和用于围绕叶轮的轴密封的一体式密封构件。 密封构件固定地连接到轴颈上，使得密封构件由轴颈支撑。 本发明还涉及用于向血液泵提供动力以使血液能够通过套管泵送的装置。 提供装置包括具有用于感测泵故障的装置的控制器和用于在泵故障的情况下致动安全闭塞器的输出端子。 优选地，存在围绕插管设置并与输出端子连通的安全闭塞器装置。 优选地，血泵包括具有定子机构的马达和由定子机构驱动的转子机构。 感测装置包括用于确定定子机构内的反向电磁力的装置。 优选地，控制装置具有分别提供定子电流和转子速度的信号的装置。 提供装置与用于确定定子机构中的反向电磁力的装置通信。